With a demand for Omicron-targeted boosters, Pfizerโs third-quarter sales of the COVID shot came in at $4.4 billion, blowing past estimates of $2.6 billion https://t.co/khCyXeOdPG pic.twitter.com/DObDhWrFlB— Reuters (@Reuters) November 1, 2022
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)













Quickly


